GlassScriptPhysician profile
Alan R Posner
NPI 1063422020
$44,279.04
in general payments reported to CMS, 2019-2025
26 companies · $29K in 2025
The $29K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,635 · 2020: $1,437 · 2021: $219 · 2022: $429 · 2023: $1,244 · 2024: $8,870 · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Travel and Lodging: $7,685 · Food and Beverage: $2,693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $29,180.00 |
| Travel and Lodging | $7,685.08 |
| Food and Beverage | $2,692.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $26,747.15 | 2020-2025 | N/A |
| Distalmotion US | $6,626.70 | 2024 | Dexter L6 Robot |
| Medical Device Business Services, INC. | $3,351.80 | 2025 | |
| Asensus Surgical, INC. | $2,369.26 | 2019 | |
| Medtronic, INC. | $2,222.47 | 2022-2025 | Ligasure, Progrip |
| Apollo Endosurgery US INC | $538.07 | 2023 | Overstitch Endoscopic Suturing System |
| Novo Nordisk INC | $441.96 | 2020-2025 | Wegovy |
| New View Surgical, INC. | $347.57 | 2023 | Visionport System |
| Lucid Diagnostics INC. | $310.81 | 2023 | |
| Activ Surgical, INC. | $255.06 | 2022 | |
| Ethicon US, LLC | $174.59 | 2019-2021 | |
| Endogastric Solutions, INC | $145.68 | 2024 | Esophyx |
| Conmed Corporation | $117.49 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $110.00 | 2019 | |
| Allergan, INC. | $94.80 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encision INC | $89.28 | 2024 | |
| Solventum Corporation | $74.38 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Boston Scientific Corporation | $53.54 | 2021-2024 | Spyglass Discover |
| Abbvie INC. | $51.77 | 2023-2025 | |
| Smith+Nephew, INC. | $42.52 | 2023-2025 | Pico, Renasys Touch, Renasys Go V2 Home |
| Intra-Sana Laboratories | $24.49 | 2021 | |
| Medela LLC | $21.01 | 2024 | Invia Motion Endure |
| Stryker Corporation | $20.17 | 2024 | Aim (Advanced Imaging Modality) |
| Steris Corporation | $19.85 | 2024 | |
| Lilly USA, LLC | $15.69 | 2024 | Zepbound |
| W. L. Gore & Associates, INC. | $12.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Posner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.